Biggest News Aggregation in the World
📰 Next Biotech News

Next Biotech News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Next Biotech. Real-time updates on events, politics, business and more.

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - PHAXIAM Therapeutics (NASDAQ:PHXM)

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant
France General United States United Kingdom New York Pharma Bio Enregistrement Universel

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus - PHAXIAM Therapeutics (NASDAQ:PHXM)

Approval of study design by French ANSM and Ethics Committee Recruitment of 12 patients expected to start in Q4 2023 in 4 French centersFirst study results expected in mid-2024 Lyon (France) et Cambridge (MA, US),
France General United States Le Moing Enregistrement Universel Pascal Birman Pharma Bio

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science